Farxiga Uses: What Dapagliflozin Treats Beyond Type 2 Diabetes

Farxiga Uses: What Dapagliflozin Treats Beyond Type 2 Diabetes

Dapagliflozin (brand name Farxiga) is best known as a treatment for type 2 diabetes. In recent years, however, research has shown it can help with other chronic conditions—particularly those involving the heart and kidneys. Below, we’ll review what Farxiga does, how it works beyond blood sugar control, and what you should know if you and your doctor are considering it for conditions other than diabetes.

How Farxiga Works
Farxiga belongs to a class of medications called SGLT2 inhibitors. These drugs lower blood sugar by blocking the sodium-glucose co-transporter 2 (SGLT2) in your kidneys, causing excess glucose to be excreted in the urine. Along with its sugar-lowering effect, dapagliflozin also:

• Promotes mild diuresis (more urine output)
• Lowers blood pressure
• Reduces intraglomerular pressure in the kidneys
• Modestly aids weight loss

These actions help explain why Farxiga is now approved for other conditions.

Approved Farxiga Uses

1. Type 2 Diabetes
   • Improves glycemic control when diet and exercise aren’t enough
   • Lowers HbA1c by about 0.5–0.8% on average
   • Can be used alone or with other glucose-lowering drugs

2. Heart Failure with Reduced Ejection Fraction (HFrEF)
   • Reduces the risk of hospitalization for heart failure by about 30%
   • Lowers cardiovascular death in patients with ejection fraction ≤40%
   • Benefits seen whether or not patients have diabetes

3. Chronic Kidney Disease (CKD)
   • Slows progression of kidney damage in people with and without type 2 diabetes
   • Reduces risk of end-stage kidney disease, dialysis, or transplantation
   • Improves albuminuria (protein in urine) and estimated glomerular filtration rate (eGFR) over time

Potential Off-Label Uses Under Investigation

• Heart failure with preserved ejection fraction (HFpEF)
– Early studies suggest symptom improvement and fewer hospitalizations
• Non-alcoholic fatty liver disease (NAFLD)
– May decrease liver fat content and inflammation
• Obesity
– Modest weight loss seen in trials, though not officially approved for weight management

What the Evidence Shows
Clinical trials have expanded Farxiga’s role significantly:

• DAPA-HF Trial (HFrEF)
– Enrolled patients with ejection fraction ≤40%, with or without diabetes
– 26% reduction in CV death or heart failure hospitalization over 18 months

• DAPA-CKD Trial
– Included CKD patients (eGFR 25–75 mL/min/1.73 m2), with albuminuria
– 39% reduction in kidney‐specific outcomes

• DELIVER and EMPA-Preserved (HFpEF)
– Ongoing trials indicating benefit, though not yet fully approved for HFpEF

Safety and Common Side Effects
Farxiga is generally well tolerated, but you and your doctor should monitor for:

• Genital mycotic infections (yeast infections)
• Urinary tract infections
• Dehydration or low blood pressure (especially in older adults)
• Increased urination
• Rarely, euglycemic diabetic ketoacidosis (more common in type 1 diabetics; Farxiga is not approved for type 1)

Before starting Farxiga, your doctor will check kidney function and volume status. Periodic monitoring of electrolytes, kidney tests, and blood pressure helps ensure safe use, especially in heart or kidney disease.

Who Should Consider Farxiga Beyond Diabetes?
Your doctor may discuss Farxiga if you have:

• Heart failure with reduced ejection fraction, even if you don’t have diabetes
• Chronic kidney disease with albuminuria, regardless of diabetic status
• A combination of type 2 diabetes, heart failure, and/or CKD

Deciding on Farxiga involves weighing benefits (reduced hospitalizations, slower CKD progression) against risks (infections, dehydration). If you’re experiencing symptoms such as swelling, fatigue, or changes in urination, it may help to do a free, online symptom check, using the doctor approved Ubie Symptom Checker (https://ubiehealth.com/) before your appointment.

Questions to Ask Your Doctor
• Is Farxiga right for my heart or kidney condition?
• What tests do I need before starting this medication?
• How will we monitor for side effects?
• Are there lifestyle changes I should make alongside Farxiga?

Practical Tips for Taking Farxiga
• Take once daily, with or without food.
• Stay well-hydrated, especially in hot weather or during exercise.
• Maintain good genital hygiene to lower infection risk.
• Continue monitoring blood pressure and kidney function as recommended.

When to Seek Help
While Farxiga can offer important benefits, any of the following warrant prompt medical attention:

• Signs of severe dehydration (dizziness, fainting)
• High fever, severe abdominal pain, or rapid breathing (potential ketoacidosis)
• Signs of serious infection (high fever, chills, severe pain)
• Sudden shortness of breath or chest pain

If you experience any life-threatening or serious symptoms, speak to a doctor right away.

Key Takeaways
• Farxiga (dapagliflozin) is approved for type 2 diabetes, heart failure (HFrEF), and chronic kidney disease.
• Its blood-pressure‐lowering and diuretic effects benefit heart and kidney health, even without diabetes.
• Common side effects include genital and urinary infections; rare but serious risks exist.
• Work closely with your doctor on monitoring and dose adjustments.
• Consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker before your visit.

Always discuss any new or worsening symptoms with your healthcare provider. Farxiga offers promising benefits beyond blood sugar control, but personalized medical advice is essential. Speak to a doctor about whether Farxiga fits your treatment plan—and what monitoring you’ll need to stay safe and well.